Sema Yılmaz Rakıcı

14PUBLICATIONS
24CO-AUTHORS
Instruments and techniquesPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 13, 2026
Clinical Impact of PSMA PET Fusion-Based RT Planning on Dosimetry and PSA Response in Prostate Cancer.

|Feb 24, 2026
Response to letter regarding: "sarcopenia is a bad harbinger of cancer-related survival in rectal cancer".

Sema Yilmaz Rakici

|Dec 19, 2025
Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer.

Sema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi

|Nov 27, 2025
Could Different Doses of Dexmedetomidine Be as Effective as Amifostine Against Radiotherapy-Induced Liver Injury in Rats? Evidence from Mitotic, Apoptotic, Oxidative, and Neurogenic Insights.

Hatice Beyazal Polat, Hamit Yilmaz, Kasım Demir

|Oct 29, 2025
Dexmedetomidine as a Protective Agent Against X-Ray Ionizing Radiation-Induced Small Intestinal Injury.

Süleyman Kalcan, Levent Tumkaya, Tolga Mercantepe

|Sep 27, 2025
A Dose-Dependent Study Examining Dexmedetomidine's Possible Effects Against Oxidative, Fibrotic, and Apoptotic Damage Induced by Radiation Exposure in Spleen Tissue.

Hatice Beyazal Polat, Hamit Yılmaz, Kagan Kilinc

Pageof 3

Frequent Collaborators

4 joint publications

Tolga Mercantepe

3 joint publications

Levent Tumkaya

3 joint publications

Hamit Yılmaz

2 joint publications

Filiz Mercantepe